EW

Inspire Medical Systems (INSP) shares gained 47.8% over three months as reimbursement uncertainty eases following new CPT code approvals and better-than-expected Q2 results. The company reported $200.6M in revenues and 14 cents adjusted EPS, while Project Horizon aims to redirect $30M in annualized savings toward growth initiatives. However, near-term sales remain disrupted and full execution risks persist.

DaVita (DVA) shares have gained 55.6% year-to-date, outpacing industry growth, driven by better operating execution, improved treatment-volume outlook, and growing confidence in value-based kidney care. The company reaffirmed 2026 guidance with expected earnings growth of 50.6% on 3.2% sales growth, supported by higher revenue per treatment and labor productivity gains. However, risks include insurance-mix headwinds from ACA subsidy losses, rising patient-care costs, and uncertain Medicare reimbursement policies.

Intuitive Surgical's single-port (SP) platform is emerging as a significant growth franchise with 61% year-over-year procedure growth and an installed base of 445 systems. Strong U.S. utilization gains (25% YoY) and expanding stapler adoption (nearly 60% of eligible cases) support the platform's trajectory toward becoming a billion-dollar business. The company is also expanding internationally and through product innovation.